Markets

Health Care Sector Update for 12/21/2015: AEGR, RXII

Top Health-care stocks:

JNJ: flat

PFE: flat

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade on Monday.

In health-care stocks news, biopharmaceutical company Aegerion Pharmaceuticals ( AEGR ) has been upgraded by Guggenheim Securities to a buy rating from a sell. The firm also raised its price target on the stock to $13 from $7 a share.

Shares in the company were 3.2% higher at $9.30 pre-bell. This is within the lower band of the stock's 52 week trading range between $8.68 and $28.97.

And RXI Pharmaceuticals ( RXII ) said it has begun a Phase 2 clinical trial to evaluate the safety and clinical activity of Samcyprone on the clearance of cutaneous warts.

Shares in the company were unchanged at $0.40 pre-bell. This is within the lower band of the stock's 52 week trading range between $0.34 and $1.74.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More